Evidence map›Paper›PMID 32419831›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2020

Efficacy of Pleuran (

Ingrid Urbancikova, Dana Hudackova, Juraj Majtan, Zuzana Rennerova, Peter Banovcin, Milos Jesenak

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Glucans: A Therapeutic Alternative for Sepsis Treatment.Journal of immunology research · 2024
    Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Medicinal Mushrooms: Bioactive Compounds, Use, and Clinical Trials.International journal of molecular sciences · 2021
    Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Ingrid UrbancikovaDepartment of Pediatrics, P. J. Safarik University, Faculty of Medicine, Children Faculty Hospital, Trieda SNP 1, 040 11 Kosice, Slovakia.
Dana HudackovaDepartment of Pediatric Infectology, Children Faculty Hospital, Faculty of Medicine, Trieda SNP 1, 040 11 Kosice, Slovakia.
Juraj MajtanInstitute of Molecular Biology, Slovak Academy of Sciences, Dubravska Cesta 21, 845 51 Bratislava, Slovakia.ORCID https://orcid.org/0000-0002-7268-1584
Zuzana RennerovaPneumo-Allergo Centre Ltd., Udernicka 1, 851 01 Bratislava, Slovakia.ORCID https://orcid.org/0000-0003-3682-3298
Peter BanovcinDepartment of Paediatrics, Jessenius Faculty of Medicine, Comenius University in Bratislava, Kollarova 2, 036 59 Martin, Slovakia.
Milos JesenakDepartment of Paediatrics, Jessenius Faculty of Medicine, Comenius University in Bratislava, Kollarova 2, 036 59 Martin, Slovakia.ORCID https://orcid.org/0000-0001-7976-2523
Comenius University Bratislava · SKSlovak Academy of Sciences · SKSlovak Medical University · SKUniversity of Pavol Jozef Šafárik · SKUniversity of Veterinary Medicine in Košice · SK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the highly prevalent viral pathogens among children and adults causing infection, clinically presenting as herpes labialis, is herpes simplex virus type 1 (HSV-1). The long-term administration of acyclovir, a standard regimen for therapy against HSV-1 infections, can cause viral resistance against this drug. Therefore, the development of natural drugs with low toxicity that are able to enhance host antiviral defense against HSV infection is needed.

Identifiers

PMID32419831
PMCPMC7201855
OpenAlexW3015954557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.